MK-0472 clinical trials

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

This study looks at a new treatment called MK-0472 for advanced or spreading cancers. It's given alone or with other medicines like pembrolizumab or MK-1084 to see how well it works and if it's safe.